Orders approved before 3pm on a weekday can be dispatched by our General Pharmaceutical Council-registered pharmacy for next-day delivery, and all medications are packaged in plain, discreet packaging
Most researchers and trial participants treat Retatrutide as a long-term tool, similar to how Semaglutide and Tirzepatide are used on an ongoing basis

Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals
AgeRejuvenation builds each Epithalon protocol around your biology and oversees it over time
The medication works by slowing gastric emptying and increasing feelings of fullness, changes that persist only while the drug remains active in your system
After the initial injection, patients often observe improvements